Sir Keith O’Nions - Board Chairman
Sir Keith O’Nions, a Cambridge scientist and former President and Rector of Imperial College London, is Chairman of the Cambridge Enterprise Board. This is a return to Cambridge for Sir Keith, who held a Royal Society Research Chair at the University from 1979 to 1995. He joined Imperial College in 2008 and in 2010 was appointed as Rector.
Among his many distinguished roles in academia and government, Sir Keith O’Nions served as the Director General of the UK’s seven Research Councils where he managed an annual multi-billion pound budget and developed the UK science and innovation policy and strategy. He was Chief Scientific Adviser for the UK Ministry of Defence, Head of Earth Sciences and Professor of Physics and Chemistry Minerals at the University of Oxford, and Director General, Science and Innovation, in the Department for Innovation, Universities and Skills.
Sir Keith received a knighthood for services to Earth Sciences in the 1999 Queen’s Birthday Honours and was elected a Fellow of the Royal Society in 1983.
Dr Tony Raven - Chief Executive
Dr Tony Raven joined Cambridge Enterprise as Chief Executive in December 2011. Previously he was Director of Research & Innovation Services at the University of Southampton, where he helped establish Southampton’s international reputation as a leading entrepreneurial university, creating a portfolio of 11 spin-out companies with four listings on the London Stock Exchange.
After graduating with a First in physics from Manchester University, he obtained his MSc and DPhil from the University of Oxford. He worked at Rutherford Appleton Laboratories and Osaka University before joining Cambridge-based PA Consulting in 1983.
In 1985 he was a founder of Summit Technology, the market leader in laser refractive surgery, which was acquired by Nestlé Alcon in 2000 for $893 million. In 1987 he co-founded Cambridge-based Sagentia Group plc, a technical and management consultancy which is listed on the London Stock Exchange. In 1991 he founded Diomed Inc, a pioneer and world leader in therapeutic medical diode lasers, and served as CEO and Deputy Chairman until 2000.
Dr Raven is a Fellow of the Institute of Physics and a Member of the Institute of Directors.
Dr Paul Seabright - Deputy Director
Paul joined Cambridge Enterprise in April 2009 to take up the post as Head of Consultancy Services. In 2010 he was a Board member and Director of Cambridge University Technical Services Limited (CUTS), a consultancy company wholly owned by Cambridge Enterprise Limited.
Paul has a degree in Biochemistry and a PhD in Chemistry from Manchester. He has considerable experience of technology transfer in both the biotech and medtech sectors and was previously Head of Business Development at Health Enterprise East, where he was instrumental in building a successful technology transfer and consultancy organisation for the NHS. Before that, he was a technology manager at Cambridge Enterprise for more than three years and led its Life Sciences team. Paul also spent five years as a senior scientist with a Cambridge biotech company developing its medtech business, and has been a postdoctoral researcher with the MRC and the University of Cambridge.
Professor Alan Blackwell - Reader in Interdisciplinary Design, University of Cambridge
Alan Blackwell is Reader in Interdisciplinary Design at the University of Cambridge Computer Laboratory, having prior qualifications in professional engineering, computing and experimental psychology.
He has more than 30 years’ experience of designing industrial systems, electronic and software products, including periods as a design consultant, researcher and lead product designer for a wide variety of companies. He has taught design courses and supervised postgraduate design research students in computing, architecture, psychology, languages, music and engineering. He is a Fellow of Darwin College, and Co-director of the Crucible network for research in interdisciplinary design.
Charles Cotton - Cambridge Phenomenon Limited
Charles Cotton is Founder and Chairman of Cambridge Phenomenon International Ltd. He co-authored The Cambridge Phenomenon 50 Years of Innovation and Enterprise, which will also be published in Mandarin in Summer 2015. The next book in the series, The Cambridge Phenomenon: Global Impact is scheduled for publication in Spring 2016. He is a Director of Solarflare Inc.; XMOS Ltd; Cambridge Enterprise and is a member of its Investment Committees; Chairman of the Advisory Panel of Cambridge Innovation Capital; Deputy Chairman of Cambridge Ahead; a member of the Board of Trustees of the American University of Sharjah; and chairs the Advisory Panel for CUER (Cambridge University ECO Racing).
Previously he was a Supervisory Board member of Euronext Amsterdam listed, Tele Atlas which was sold to TomTom for $4.3Bn in 2008; Executive Chairman of NASDAQ listed, GlobespanVirata Inc.; and CEO of Virata Corp. which he took public on NASDAQ in 1999 and achieved a market cap of more than $5Bn at its peak.
Prior to that he was President of Thermal Scientific Inc, and a Director of London Stock Exchange listed Thermal Scientific Ltd. His engagement in high technology dates back to 1983 when he was Sales and Marketing Director at Sinclair Research Ltd. After graduating, he worked in the automotive industry at British Leyland and Ford.
He holds a BA Hons in Physics from Oxford University and is a Fellow of the Institute of Physics and a Fellow of the Royal Society of Arts.
Professor Andy Neely - Pro-Vice-Chancellor (Enterprise & Business Relations)
Professor Andy Neely is Pro-Vice-Chancellor for Enterprise and Business Relations at the University of Cambridge, Head of the Institute for Manufacturing (IfM) and Head of the Manufacturing and Management Division of Cambridge University Engineering Department. He is a Fellow of Sidney Sussex College and Founding Director of the Cambridge Service Alliance. He is widely recognised for his work on the servitisation of manufacturing, as well as his work on performance measurement and management.
Previously Andy has held appointments at Cranfield University, London Business School, Cambridge University, where he was a Fellow of Churchill College, Nottingham University, where he completed his PhD and British Aerospace. He was Deputy Director of AIM Research – the UK’s management research initiative – from 2003 until 2012 and was elected a Fellow of the British Academy of Management in 2007, a Fellow of the Academy of Social Science in 2008 and a Fellow of the European Operations Management Association in 2009.
Dr Jane Osbourn - Vice President of Research & Development, MedImmune
Jane Osbourn PhD is VP Research and Development and Site Leader for MedImmune in Cambridge, having joined MedImmune (formerly Cambridge Antibody Technology (CAT) and now the global biologics research and development arm of AstraZeneca) in 1993.
An expert in antibody engineering, she originated several key publications and patents, and has also made a significant contribution to the discovery and development of marketed drugs (Humira and Benlysta) and more than 40 clinical candidates. Jane is Chair of the Board of Directors of the BioIndustry Association, a Director of Babraham Bioscience Technologies, a Director of Cambridge Enterprise and has presented at a number of parliamentary Select Committees.
Debu Purkayastha - Entrepreneur-in-Residence, Octopus Investments
Purkayastha is currently Entrepreneur-in-Residence (EiR) at Octopus Investments, a premier European investment firm with $8bn-plus under management. He has significant operating and Investment/M&A experience - in the US, Europe, Asia and Africa. Until 2014, he spent almost six years at Google. He was Principal - New Business Development at Google and was instrumental in launching several of Google’s iconic products globally spanning multiple key strategic focus areas. Previously, he was Google's Principal - Corporate Development - spearheading its global M&A and Investment efforts including many landmark acquisitions and investments in US and Europe. He is also a founding member of Google “Campus,” a seven-storey co-working space for start-ups in London’s Tech City (which has been widely covered by the global media).
Purkayastha is also a Senior Advisor to EQT (global private equity fund), sits on the Board of MercyCorps (international NGO), Advisory Boards of Vimpelcom (mobile telco) and Sadara Ventures (VC fund) and previously sat on the Boards of Fon (wireless), Mobile Planet (mobile apps), Reevoo (reviews) and HTL/Scandic (biggest hotel chain in Scandinavia).
Prior to Google, he headed Sabre’s Corporate Development/M&A team and in a past life was a Telecoms/Media/Technology M&A Banker with Salomon Smith Barney/Citigroup in Silicon Valley, Wall Street and London.
He has a MBA from London Business School and is a qualified Chartered Accountant.
He spends a fair bit of his personal time working with leading NGOs and governmental institutions in several politically sensitive and conflict zones including Palestine, Iraq, Syria, Kashmir etc., focusing on economic development initiatives (primarily helping fund and build small businesses). A certified cricket nut and film fanatic and is also passionate about white-water rafting & hiking.
Emma Rampton - Company Secretary
Emma Rampton is the Acting Registrary at the University of Cambridge. She joined Cambridge in 2015 as Academic Secretary and was appointed Acting Registrary from 1 January 2017 following the retirement of Jonathan Nicholls.
Before Cambridge, Emma worked at the University of Oxford. She was there for over ten years, first as the Head of Administration in the Faculty of Law and latterly as Deputy University Secretary, a role in which she had responsibility for overseeing the University’s governance, compliance and assurance processes. Emma graduated from St John’s College, Oxford, after which she qualified as a lawyer.
Professor Florin Udrea - Professor of Semiconductor Engineering, University of Cambridge
Image: University shield, courtesy the University of Cambridge.